These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22609385)

  • 21. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.
    Cotton CC; Wolf WA; Overholt BF; Li N; Lightdale CJ; Wolfsen HC; Pasricha S; Wang KK; Shaheen NJ;
    Gastroenterology; 2017 Sep; 153(3):681-688.e2. PubMed ID: 28579538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett's esophagus.
    Korst RJ; Santana-Joseph S; Rutledge JR; Antler A; Bethala V; DeLillo A; Kutner D; Lee BE; Pazwash H; Pittman RH; Rahmin M; Rubinoff M
    J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1529-34. PubMed ID: 23219501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of surgical patients with gastroesophageal reflux disease and Barrett's esophagus].
    Zsolt S; Paszt A; Géczi T; Abrahám S; Tóth I; Horváth Z; Pieler J; Tajti J; Varga A; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Lázár G
    Magy Seb; 2014 Oct; 67(5):287-96. PubMed ID: 25327403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of liquid nitrogen cryotherapy after failed radiofrequency ablation for Barrett's esophagus.
    Trindade AJ; Inamdar S; Kothari S; Berkowitz J; McKinley M; Kaul V
    Dig Endosc; 2017 Sep; 29(6):680-685. PubMed ID: 28303613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of Barrett's esophagus with dysplasia refractory to radiofrequency ablation.
    Raphael KL; Trindade AJ
    World J Gastroenterol; 2020 May; 26(17):2030-2039. PubMed ID: 32536772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure.
    Wakelin DE; Al-Mutawa T; Wendel C; Green C; Garewal HS; Fass R
    Gastrointest Endosc; 2003 Sep; 58(3):350-5. PubMed ID: 14528207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence of Barrett's Esophagus is Rare Following Endoscopic Eradication Therapy Coupled With Effective Reflux Control.
    Komanduri S; Kahrilas PJ; Krishnan K; McGorisk T; Bidari K; Grande D; Keefer L; Pandolfino J
    Am J Gastroenterol; 2017 Apr; 112(4):556-566. PubMed ID: 28195178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomy.
    O'Riordan JM; Tucker ON; Byrne PJ; McDonald GS; Ravi N; Keeling PW; Reynolds JV
    Am J Gastroenterol; 2004 Feb; 99(2):205-11. PubMed ID: 15046206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prior fundoplication does not improve safety or efficacy outcomes of radiofrequency ablation: results from the U.S. RFA Registry.
    Shaheen NJ; Kim HP; Bulsiewicz WJ; Lyday WD; Triadafilopoulos G; Wolfsen HC; Komanduri S; Chmielewski GW; Ertan A; Corbett FS; Camara DS; Rothstein RI; Overholt BF
    J Gastrointest Surg; 2013 Jan; 17(1):21-8; discussion p.28-9. PubMed ID: 22965650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett's esophagus: a critical assessment of histologic outcomes and adverse events.
    Chadwick G; Groene O; Markar SR; Hoare J; Cromwell D; Hanna GB
    Gastrointest Endosc; 2014 May; 79(5):718-731.e3. PubMed ID: 24462170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy.
    Zaninotto G; Parente P; Salvador R; Farinati F; Tieppo C; Passuello N; Zanatta L; Fassan M; Cavallin F; Costantini M; Mescoli C; Battaglia G; Ruol A; Ancona E; Rugge M
    J Gastrointest Surg; 2012 Jan; 16(1):7-14; discussion 14-5. PubMed ID: 22086718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Barrett's esophagus].
    Kauer WK; Stein HJ; Dittler HJ; Siewert JR
    Chirurg; 2005 Mar; 76(3):258-62. PubMed ID: 15580449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
    Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
    Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of buried Barrett's metaplasia in patients before and after radiofrequency ablation.
    Yuan J; Hernandez JC; Ratuapli SK; Ruff KC; De Petris G; Lam-Himlin DM; Burdick GE; Pannala R; Ramirez FC; Fleischer DE
    Endoscopy; 2012 Nov; 44(11):993-7. PubMed ID: 23108770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus.
    Shaheen NJ; Peery AF; Overholt BF; Lightdale CJ; Chak A; Wang KK; Hawes RH; Fleischer DE; Goldblum JR;
    Gastrointest Endosc; 2010 Sep; 72(3):490-496.e1. PubMed ID: 20598302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective intra-esophageal acid control is associated with improved radiofrequency ablation outcomes in Barrett's esophagus.
    Akiyama J; Marcus SN; Triadafilopoulos G
    Dig Dis Sci; 2012 Oct; 57(10):2625-32. PubMed ID: 22878916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.
    Basu KK; Bale R; West KP; de Caestecker JS
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1187-92. PubMed ID: 12439112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of intestinal metaplasia after successful eradication of Barrett's Esophagus with radiofrequency ablation.
    Vaccaro BJ; Gonzalez S; Poneros JM; Stevens PD; Capiak KM; Lightdale CJ; Abrams JA
    Dig Dis Sci; 2011 Jul; 56(7):1996-2000. PubMed ID: 21468652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.